Show newer

📢 The highlights of our Management Board meeting are now available & include updates on:
✅approval of cancer medicines with potential to transform patient care
✅ recent initiatives on clinical trials in the EU
👉ema.europa.eu/en/news/ema-mana

🐦🔗: n.respublicae.eu/EMA_News/stat

Today we're discussing priorities for incl.
▶️Improving & fostering health
▶️Protecting people
▶️Enhancing access to medicinal products & medical devices
▶️Preparing health systems for the digital era
▶️Synergies & complementarities

europa.eu/!jHjdvJ

🐦🔗: n.respublicae.eu/EU_Health/sta

The 2024 2-stage Health calls are still open for applications!

Check out available funding for research on access to innovative, sustainable and high-quality for people in vulnerable situations

📌Deadline: 19 September
hadea.ec.europa.eu/news/4-two-

🐦🔗: n.respublicae.eu/EU_HaDEA/stat

Today, we've published a report to support the understanding and work on health promotion and disease prevention, contributing to national health system performance assessment frameworks.
Read more & register for the launch event: europa.eu/!VHFmdM

🐦🔗: n.respublicae.eu/EU_Health/sta

The 2nd wave of the 2023 calls for action grants will open soon!

Save the date for the upcoming info session to present the policy context, objectives, expected impact and procedure

📌30 June 2023

hadea.ec.europa.eu/events/info

🐦🔗: n.respublicae.eu/EU_HaDEA/stat

Just published!

A new scientific paper 📰on designs and statistical approaches applied in COVID-19 vaccine efficacy trials is now available.

It focuses on the first 4⃣ approved .

Click to read the full paper 👇
doi.org/10.1080/19466315.2023..

🐦🔗: n.respublicae.eu/EMA_News/stat

Today’s fast changing world impacts

With 2⃣0⃣ flagship initiatives & EUR 1.23 billion, we're helping EU countries:
▶️Make mental health a priority
▶️Support those needing help
▶️Protect children & the vulnerable

Read more: europa.eu/!XCqGfQ

🐦🔗: n.respublicae.eu/EU_Health/sta

is another building block of a strong 🇪🇺 that makes health a priority for all.

Many people still find it difficult to speak up and seek the help and answers they need.

Together, we must break this stigma.

🙌There is no health without mental health!

🐦🔗: n.respublicae.eu/SKyriakidesEU

RT @ECDC_EU: In line with the outcome of recent meetings of international regulators and the @WHO, @EMA_News Emergency Task Force recommends updating vaccines to target strains (a subgroup of ), which have become dominant in Europe and other parts of the world. t.co/gas97lAmW6

🐦🔗: n.respublicae.eu/EMA_News/stat

RT @ECDC_EU: Both agencies (@ECDC_EU & @EMA_News) note that monovalent vaccines (vaccines targeting only one strain such as XBB.1.5) are a reasonable choice to provide protection against current dominant and emerging strains.

t.co/7szyGfVoiZ

🐦🔗: n.respublicae.eu/EMA_News/stat

Have you been affected by the shortage of the medicine Visudyne ❓

Participate in our and help us improve our communication!

The aim is to collect information on how patients were informed about the recent medicine .

📩 Send your feedback by 9 June

🐦🔗: n.respublicae.eu/EMA_News/stat

EMA and the EU network will keep monitoring the of and therapeutics, as we do for all authorised medicines in the 🇪🇺.

🐦🔗: n.respublicae.eu/EMA_News/stat

Show thread

The available data confirm that the are safe and add to the evidence from the clinical trials.

Most of the side effects of the vaccines are mild and short-lived. Serious side effects are very rare.

🐦🔗: n.respublicae.eu/EMA_News/stat

Show thread

If an unusual pattern emerged, the performed an in-depth analysis of the reports to quickly identify potential safety issues with .

The 🇪🇺 pharmacovigilance system showed that it can detect and manage emerging issues quickly.

🐦🔗: n.respublicae.eu/EMA_News/stat

Show thread

We have encouraged people who received the and healthcare professionals to report suspected side effects.

Out of nearly 1 billion vaccines administered, Eudravigilance received more than 1.7 million reports in the EU.

🐦🔗: n.respublicae.eu/EMA_News/stat

Show thread
Show older
Mastodon

A Mastodon forum for the discussion of European Union matters. Not run by the EU. Powered by PleromaBot, Nitter and PrivacyDev.net.